Literature DB >> 6538039

Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus.

A S Yeager, A M Arvin.   

Abstract

Thirty-one cases of neonatal herpes simplex (HSV) infection were evaluated to determine how often mothers of infected infants lacked a history of recurrent genital infections and the reasons for its absence. A history of recurrent genital infections was elicited from eight (26%) of the mothers. Nine (29%) of the mothers had primary infections; three of these were oral and six were genital. The mother was not the source of infection in three (9.6%) cases. In eleven (35%) cases, the mother had antibody to HSV but did not have a history or findings of primary or recurrent infection. Two of these mothers had positive cervical or vaginal cultures, but neither had genital lesions typical of HSV in the perinatal period. Two mothers had recurrent HSV infections documented later. The source of the HSV infection remained uncertain in 23% of cases including two in which only the father had a history of recurrent genital infection. When mothers with primary infections in the perinatal period were excluded, the HSV neutralization titers of the mothers of infected infants were similar to the titers of the mothers with recurrent genital infections whose infants were not infected. In contrast, the infected infants had titers fourfold lower than their mother's titer as well as fourfold lower than the 16 infants exposed to HSV who remained uninfected. This discrepancy suggests that the mothers may have had a rise in titer late in pregnancy or that placental transport of antibody was limited. Although 26% of the mothers of infected infants had recurrent genital infections, only three (9.6%) had an easily elicitable history.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538039

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Herpes simplex virus infection in pregnancy.

Authors:  D McIntosh; D Isaacs
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  Preventing neonatal herpes?

Authors:  D E Mercey; A Mindel
Journal:  Genitourin Med       Date:  1991-02

Review 3.  Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes.

Authors:  R J Whitley
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

4.  Amplification techniques for detection of herpes simplex virus in neonatal and maternal genital specimens obtained at delivery.

Authors:  A L Warford; J W Chung; A E Drill; E Steinberg
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

5.  Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection.

Authors:  A E Ades; C S Peckham; G E Dale; J M Best; S Jeansson
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

6.  Periodic health examination, 1989 update: 4. Intrapartum electronic fetal monitoring and prevention of neonatal herpes simplex. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1989-12-15       Impact factor: 8.262

Review 7.  Sexually transmitted diseases in children: herpes simplex virus infection, cytomegalovirus infection, hepatitis B virus infection and molluscum contagiosum.

Authors:  A Nageswaran; G R Kinghorn
Journal:  Genitourin Med       Date:  1993-08

Review 8.  Neonatal herpes simplex infection.

Authors:  David W Kimberlin
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.

Authors:  David W Kimberlin; Jill Baley
Journal:  Pediatrics       Date:  2013-01-28       Impact factor: 7.124

10.  Pathogenesis of HSV-1/2 induced vaginitis/vulvitis of the mouse: dependence of lesions on genetic properties of the virus and analysis of pathohistology.

Authors:  M Fleck; J Podlech; K Weise; H Müntefering; D Falke
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.